Li Tai Fang

Li Tai Fang

Auto-generated profile, based on publicly available information

Li Tai Fang

Bioinformatics Research & Early Development, Roche Sequencing Solutions Inc., Belmont, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
WXWenming Xiao
Wenming Xiao
LRLuyao Ren
Luyao Ren
ZCZhong Chen
Zhong Chen
LFLi Tai Fang
Li Tai Fang
YZYongmei Zhao
Yongmei Zhao
LSLeming Shi
Leming Shi

27 April 2022 in Cell Genomics
Verified
Journal Article
Open access
NONathan Olson
Nathan Olson
JWJustin Wagner
Justin Wagner
JMJennifer McDaniel
Jennifer McDaniel
SSSarah H. Stephens
Sarah H. Stephens
SWSamuel T. Westreich
Samuel T. Westreich
JZJustin M. Zook
Justin M. Zook
The precisionFDA Truth Challenge V2 aimed to assess the state of the art of variant calling in challenging genomic regions. Starting with FASTQs, 20 challenge participants applied their variant-calling pipelines and submitted 64 variant call sets for one or more sequencing technologies (Illumina, PacBio HiFi, and Oxford Nanopore Technologies). Submissions were evaluated following best practices for benchmarking small variants with updated Genome in a Bottle benchmark sets and genome stratifications. Challenge submissions included numerous innovative methods, with graph-based and machine learning methods scoring best for short-read and long-read datasets, respectively. With machine learning approaches, combining multiple sequencing technologies performed particularly well. Recent developments in sequencing and variant calling have enabled benchmarking variants in challenging genomic regions, paving the way for the identification of previously unknown clinically relevant variants.

9 September 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
LFLi Tai Fang
Li Tai Fang
BZBin Zhu
Bin Zhu
YZYongmei Zhao
Yongmei Zhao
WCWanqiu Chen
Wanqiu Chen
ZYZhaowei Yang
Zhaowei Yang
WXWenming Xiao
Wenming Xiao

17 September 2015 in Genome Biology
Verified
Journal Article
Open access
PDF file
LFLi Tai Fang
Li Tai Fang
PAPegah Tootoonchi Afshar
Pegah Tootoonchi Afshar
ACAparna Chhibber
Aparna Chhibber
MMMarghoob Mohiyuddin
Marghoob Mohiyuddin
YFYu Fan
Yu Fan
HLHugo Y.K. Lam
Hugo Y.K. Lam
SomaticSeq is an accurate somatic mutation detection pipeline implementing a stochastic boosting algorithm to produce highly accurate somatic mutation calls for both single nucleotide variants and small insertions and deletions. The workflow currently incorporates five state-of-the-art somatic mutation callers, and extracts over 70 individual genomic and sequencing features for each candidate site. A training set is provided to an adaptively boosted decision tree learner to create a classifier for predicting mutation statuses. We validate our results with both synthetic and real data. We report that SomaticSeq is able to achieve better overall accuracy than any individual tool incorporated.

12 January 2011 in Physical Review Letters
Verified
Journal Article
Open access
PDF file
XQXiangyun Qiu
Xiangyun Qiu
DRDonald C. Rau
Donald C. Rau
VPV. Adrian Parsegian
V. Adrian Parsegian
LFLi Tai Fang
Li Tai Fang
CKCharles M. Knobler
Charles M. Knobler
WGWilliam M. Gelbart
William M. Gelbart
Using solution synchrotron x-ray scattering, we measure the variation of DNA-DNA d spacings in bacteriophage λ with mono-, di-, and polyvalent salt concentrations, for wild-type [48.5×103 base pairs (bp)] and short-genome-mutant (37.8 kbp) strains. From the decrease in d spacings with increasing salt, we deduce the relative contributions of DNA self-repulsion and bending to the energetics of packaged phage genomes. We quantify the DNA-DNA interaction energies within the intact phage by combining the measured d spacings in the capsid with measurements of osmotic pressure in DNA assemblies under the same salt conditions in bulk solution. In the commonly used Tris-Mg buffer, the DNA-DNA interaction energies inside the phage capsids are shown to be about 1kT/bp, an order of magnitude larger than the bending energies.

9 November 2021 in Scientific Data
Verified
Journal Article
Open access
PDF file
YZYongmei Zhao
Yongmei Zhao
LFLi Tai Fang
Li Tai Fang
TSTsai-Wei Shen
Tsai-Wei Shen
SCSulbha Choudhari
Sulbha Choudhari
KTKeyur Talsania
Keyur Talsania
WXWenming Xiao
Wenming Xiao
With the rapid advancement of sequencing technologies, next generation sequencing (NGS) analysis has been widely applied in cancer genomics research. More recently, NGS has been adopted in clinical oncology to advance personalized medicine. Clinical applications of precision oncology require accurate tests that can distinguish tumor-specific mutations from artifacts introduced during NGS processes or data analysis. Therefore, there is an urgent need to develop best practices in cancer mutation detection using NGS and the need for standard reference data sets for systematically measuring accuracy and reproducibility across platforms and methods. Within the SEQC2 consortium context, we established paired tumor-normal reference samples and generated whole-genome (WGS) and whole-exome sequencing (WES) data using sixteen library protocols, seven sequencing platforms at six different centers. We systematically interrogated somatic mutations in the reference samples to identify factors affecting detection reproducibility and accuracy in cancer genomes. These large cross-platform/site WGS and WES datasets using well-characterized reference samples will represent a powerful resource for benchmarking NGS technologies, bioinformatics pipelines, and for the cancer genomics studies.